nodes	percent_of_prediction	percent_of_DWPC	metapath
Regadenoson—ADORA2A—Aminophylline—chronic obstructive pulmonary disease	0.787	1	CbGbCtD
Regadenoson—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000416	0.00195	CcSEcCtD
Regadenoson—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000414	0.00194	CcSEcCtD
Regadenoson—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000408	0.00191	CcSEcCtD
Regadenoson—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000408	0.00191	CcSEcCtD
Regadenoson—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000404	0.00189	CcSEcCtD
Regadenoson—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000404	0.00189	CcSEcCtD
Regadenoson—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000402	0.00189	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000401	0.00188	CcSEcCtD
Regadenoson—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000399	0.00187	CcSEcCtD
Regadenoson—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000398	0.00187	CcSEcCtD
Regadenoson—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000398	0.00187	CcSEcCtD
Regadenoson—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000398	0.00187	CcSEcCtD
Regadenoson—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000395	0.00185	CcSEcCtD
Regadenoson—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000392	0.00184	CcSEcCtD
Regadenoson—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000392	0.00184	CcSEcCtD
Regadenoson—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00039	0.00183	CcSEcCtD
Regadenoson—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000385	0.00181	CcSEcCtD
Regadenoson—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000385	0.0018	CcSEcCtD
Regadenoson—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.0018	CcSEcCtD
Regadenoson—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000382	0.00179	CcSEcCtD
Regadenoson—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000381	0.00179	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00038	0.00178	CcSEcCtD
Regadenoson—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00038	0.00178	CcSEcCtD
Regadenoson—Cough—Formoterol—chronic obstructive pulmonary disease	0.00038	0.00178	CcSEcCtD
Regadenoson—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000377	0.00177	CcSEcCtD
Regadenoson—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000376	0.00176	CcSEcCtD
Regadenoson—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000376	0.00176	CcSEcCtD
Regadenoson—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.00176	CcSEcCtD
Regadenoson—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000372	0.00175	CcSEcCtD
Regadenoson—Cough—Montelukast—chronic obstructive pulmonary disease	0.000372	0.00175	CcSEcCtD
Regadenoson—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000371	0.00174	CcSEcCtD
Regadenoson—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.00174	CcSEcCtD
Regadenoson—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000371	0.00174	CcSEcCtD
Regadenoson—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000371	0.00174	CcSEcCtD
Regadenoson—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000371	0.00174	CcSEcCtD
Regadenoson—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000371	0.00174	CcSEcCtD
Regadenoson—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000371	0.00174	CcSEcCtD
Regadenoson—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000371	0.00174	CcSEcCtD
Regadenoson—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000369	0.00173	CcSEcCtD
Regadenoson—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000369	0.00173	CcSEcCtD
Regadenoson—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000369	0.00173	CcSEcCtD
Regadenoson—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000369	0.00173	CcSEcCtD
Regadenoson—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000369	0.00173	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000368	0.00173	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000368	0.00173	CcSEcCtD
Regadenoson—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000366	0.00172	CcSEcCtD
Regadenoson—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000366	0.00172	CcSEcCtD
Regadenoson—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.0017	CcSEcCtD
Regadenoson—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000363	0.0017	CcSEcCtD
Regadenoson—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000363	0.0017	CcSEcCtD
Regadenoson—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000362	0.0017	CcSEcCtD
Regadenoson—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000361	0.00169	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00036	0.00169	CcSEcCtD
Regadenoson—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00036	0.00169	CcSEcCtD
Regadenoson—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000359	0.00168	CcSEcCtD
Regadenoson—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000355	0.00167	CcSEcCtD
Regadenoson—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000355	0.00167	CcSEcCtD
Regadenoson—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000355	0.00166	CcSEcCtD
Regadenoson—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00035	0.00164	CcSEcCtD
Regadenoson—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00035	0.00164	CcSEcCtD
Regadenoson—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00035	0.00164	CcSEcCtD
Regadenoson—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00035	0.00164	CcSEcCtD
Regadenoson—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000349	0.00164	CcSEcCtD
Regadenoson—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000348	0.00163	CcSEcCtD
Regadenoson—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000348	0.00163	CcSEcCtD
Regadenoson—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000348	0.00163	CcSEcCtD
Regadenoson—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000348	0.00163	CcSEcCtD
Regadenoson—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000347	0.00163	CcSEcCtD
Regadenoson—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000347	0.00163	CcSEcCtD
Regadenoson—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000346	0.00162	CcSEcCtD
Regadenoson—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000345	0.00162	CcSEcCtD
Regadenoson—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000345	0.00162	CcSEcCtD
Regadenoson—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000344	0.00161	CcSEcCtD
Regadenoson—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000341	0.0016	CcSEcCtD
Regadenoson—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000341	0.0016	CcSEcCtD
Regadenoson—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000338	0.00159	CcSEcCtD
Regadenoson—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000335	0.00157	CcSEcCtD
Regadenoson—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000332	0.00156	CcSEcCtD
Regadenoson—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000332	0.00156	CcSEcCtD
Regadenoson—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.00155	CcSEcCtD
Regadenoson—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000329	0.00154	CcSEcCtD
Regadenoson—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000327	0.00154	CcSEcCtD
Regadenoson—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000326	0.00153	CcSEcCtD
Regadenoson—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000324	0.00152	CcSEcCtD
Regadenoson—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00152	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000324	0.00152	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000324	0.00152	CcSEcCtD
Regadenoson—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000321	0.00151	CcSEcCtD
Regadenoson—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000321	0.00151	CcSEcCtD
Regadenoson—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000319	0.0015	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000317	0.00149	CcSEcCtD
Regadenoson—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000317	0.00149	CcSEcCtD
Regadenoson—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000317	0.00149	CcSEcCtD
Regadenoson—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000316	0.00148	CcSEcCtD
Regadenoson—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000316	0.00148	CcSEcCtD
Regadenoson—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000315	0.00148	CcSEcCtD
Regadenoson—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000313	0.00147	CcSEcCtD
Regadenoson—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000312	0.00147	CcSEcCtD
Regadenoson—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000309	0.00145	CcSEcCtD
Regadenoson—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000309	0.00145	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000307	0.00144	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000307	0.00144	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000306	0.00143	CcSEcCtD
Regadenoson—Pain—Formoterol—chronic obstructive pulmonary disease	0.000304	0.00143	CcSEcCtD
Regadenoson—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000304	0.00143	CcSEcCtD
Regadenoson—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.00142	CcSEcCtD
Regadenoson—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000301	0.00141	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00141	CcSEcCtD
Regadenoson—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000299	0.0014	CcSEcCtD
Regadenoson—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000298	0.0014	CcSEcCtD
Regadenoson—Pain—Montelukast—chronic obstructive pulmonary disease	0.000298	0.0014	CcSEcCtD
Regadenoson—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000297	0.0014	CcSEcCtD
Regadenoson—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000297	0.00139	CcSEcCtD
Regadenoson—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000296	0.00139	CcSEcCtD
Regadenoson—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000294	0.00138	CcSEcCtD
Regadenoson—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000294	0.00138	CcSEcCtD
Regadenoson—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000293	0.00137	CcSEcCtD
Regadenoson—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000293	0.00137	CcSEcCtD
Regadenoson—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000292	0.00137	CcSEcCtD
Regadenoson—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000291	0.00137	CcSEcCtD
Regadenoson—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00029	0.00136	CcSEcCtD
Regadenoson—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00029	0.00136	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.00136	CcSEcCtD
Regadenoson—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000287	0.00135	CcSEcCtD
Regadenoson—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000285	0.00133	CcSEcCtD
Regadenoson—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000282	0.00132	CcSEcCtD
Regadenoson—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.00132	CcSEcCtD
Regadenoson—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000281	0.00132	CcSEcCtD
Regadenoson—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000281	0.00132	CcSEcCtD
Regadenoson—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00028	0.00131	CcSEcCtD
Regadenoson—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000278	0.0013	CcSEcCtD
Regadenoson—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000277	0.0013	CcSEcCtD
Regadenoson—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000277	0.0013	CcSEcCtD
Regadenoson—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000276	0.0013	CcSEcCtD
Regadenoson—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000276	0.0013	CcSEcCtD
Regadenoson—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000276	0.00129	CcSEcCtD
Regadenoson—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000276	0.00129	CcSEcCtD
Regadenoson—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000275	0.00129	CcSEcCtD
Regadenoson—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000274	0.00129	CcSEcCtD
Regadenoson—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.00027	0.00127	CcSEcCtD
Regadenoson—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00125	CcSEcCtD
Regadenoson—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.00124	CcSEcCtD
Regadenoson—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.00123	CcSEcCtD
Regadenoson—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000262	0.00123	CcSEcCtD
Regadenoson—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000261	0.00123	CcSEcCtD
Regadenoson—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000256	0.0012	CcSEcCtD
Regadenoson—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000255	0.0012	CcSEcCtD
Regadenoson—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000255	0.0012	CcSEcCtD
Regadenoson—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00025	0.00117	CcSEcCtD
Regadenoson—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000247	0.00116	CcSEcCtD
Regadenoson—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.00116	CcSEcCtD
Regadenoson—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000243	0.00114	CcSEcCtD
Regadenoson—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000243	0.00114	CcSEcCtD
Regadenoson—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000241	0.00113	CcSEcCtD
Regadenoson—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000238	0.00112	CcSEcCtD
Regadenoson—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000236	0.00111	CcSEcCtD
Regadenoson—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000235	0.0011	CcSEcCtD
Regadenoson—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.0011	CcSEcCtD
Regadenoson—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00023	0.00108	CcSEcCtD
Regadenoson—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.00108	CcSEcCtD
Regadenoson—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000226	0.00106	CcSEcCtD
Regadenoson—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.00106	CcSEcCtD
Regadenoson—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000224	0.00105	CcSEcCtD
Regadenoson—Rash—Formoterol—chronic obstructive pulmonary disease	0.000224	0.00105	CcSEcCtD
Regadenoson—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000224	0.00105	CcSEcCtD
Regadenoson—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000224	0.00105	CcSEcCtD
Regadenoson—Headache—Formoterol—chronic obstructive pulmonary disease	0.000223	0.00104	CcSEcCtD
Regadenoson—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.00104	CcSEcCtD
Regadenoson—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000222	0.00104	CcSEcCtD
Regadenoson—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.00104	CcSEcCtD
Regadenoson—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000221	0.00104	CcSEcCtD
Regadenoson—Rash—Montelukast—chronic obstructive pulmonary disease	0.000219	0.00103	CcSEcCtD
Regadenoson—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000219	0.00103	CcSEcCtD
Regadenoson—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000219	0.00103	CcSEcCtD
Regadenoson—Headache—Montelukast—chronic obstructive pulmonary disease	0.000218	0.00102	CcSEcCtD
Regadenoson—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000216	0.00101	CcSEcCtD
Regadenoson—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000215	0.00101	CcSEcCtD
Regadenoson—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000215	0.00101	CcSEcCtD
Regadenoson—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.001	CcSEcCtD
Regadenoson—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000213	0.000997	CcSEcCtD
Regadenoson—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.000992	CcSEcCtD
Regadenoson—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000211	0.000992	CcSEcCtD
Regadenoson—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.000991	CcSEcCtD
Regadenoson—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.00099	CcSEcCtD
Regadenoson—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000211	0.00099	CcSEcCtD
Regadenoson—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.000986	CcSEcCtD
Regadenoson—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000207	0.000972	CcSEcCtD
Regadenoson—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000207	0.00097	CcSEcCtD
Regadenoson—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000204	0.000958	CcSEcCtD
Regadenoson—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000204	0.000955	CcSEcCtD
Regadenoson—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.0002	0.00094	CcSEcCtD
Regadenoson—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.000935	CcSEcCtD
Regadenoson—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000198	0.00093	CcSEcCtD
Regadenoson—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000193	0.000907	CcSEcCtD
Regadenoson—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000192	0.000903	CcSEcCtD
Regadenoson—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.000888	CcSEcCtD
Regadenoson—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000188	0.000881	CcSEcCtD
Regadenoson—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.000873	CcSEcCtD
Regadenoson—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000184	0.000863	CcSEcCtD
Regadenoson—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000857	CcSEcCtD
Regadenoson—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000838	CcSEcCtD
Regadenoson—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000178	0.000834	CcSEcCtD
Regadenoson—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.000816	CcSEcCtD
Regadenoson—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000173	0.00081	CcSEcCtD
Regadenoson—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000809	CcSEcCtD
Regadenoson—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000804	CcSEcCtD
Regadenoson—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.000772	CcSEcCtD
Regadenoson—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000757	CcSEcCtD
Regadenoson—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000159	0.000746	CcSEcCtD
Regadenoson—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.000744	CcSEcCtD
Regadenoson—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000734	CcSEcCtD
Regadenoson—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000725	CcSEcCtD
Regadenoson—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000721	CcSEcCtD
Regadenoson—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.000717	CcSEcCtD
Regadenoson—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000706	CcSEcCtD
Regadenoson—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000696	CcSEcCtD
Regadenoson—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000694	CcSEcCtD
Regadenoson—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000684	CcSEcCtD
Regadenoson—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000684	CcSEcCtD
Regadenoson—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000682	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000679	CcSEcCtD
Regadenoson—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000676	CcSEcCtD
Regadenoson—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.000665	CcSEcCtD
Regadenoson—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000656	CcSEcCtD
Regadenoson—Shock—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000645	CcSEcCtD
Regadenoson—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000643	CcSEcCtD
Regadenoson—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00064	CcSEcCtD
Regadenoson—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000637	CcSEcCtD
Regadenoson—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000634	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000598	CcSEcCtD
Regadenoson—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.000597	CcSEcCtD
Regadenoson—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000593	CcSEcCtD
Regadenoson—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000589	CcSEcCtD
Regadenoson—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.000569	CcSEcCtD
Regadenoson—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.000569	CcSEcCtD
Regadenoson—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.000565	CcSEcCtD
Regadenoson—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000115	0.00054	CcSEcCtD
Regadenoson—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000536	CcSEcCtD
Regadenoson—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000536	CcSEcCtD
Regadenoson—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000521	CcSEcCtD
Regadenoson—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000518	CcSEcCtD
Regadenoson—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000483	CcSEcCtD
Regadenoson—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000471	CcSEcCtD
Regadenoson—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	9.56e-05	0.000449	CcSEcCtD
Regadenoson—Dizziness—Prednisone—chronic obstructive pulmonary disease	9.24e-05	0.000434	CcSEcCtD
Regadenoson—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.89e-05	0.000417	CcSEcCtD
Regadenoson—Rash—Prednisone—chronic obstructive pulmonary disease	8.81e-05	0.000414	CcSEcCtD
Regadenoson—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.81e-05	0.000413	CcSEcCtD
Regadenoson—Headache—Prednisone—chronic obstructive pulmonary disease	8.76e-05	0.000411	CcSEcCtD
Regadenoson—Nausea—Prednisone—chronic obstructive pulmonary disease	8.3e-05	0.00039	CcSEcCtD
